Exact Mass: 653.21083
Exact Mass Matches: 653.21083
Found 49 metabolites which its exact mass value is equals to given mass value 653.21083,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bromocriptine
Bromocriptine mesylate is a semisynthetic ergot alkaloid derivative with potent dopaminergic activity. It is indicated for the management of signs and symptoms of Parkinsonian Syndrome. Bromocriptine also inhibits prolactin secretion and may be used to treat dysfunctions associated with hyperprolactinemia. It also causes sustained suppression of somatotropin (growth hormone) secretion in some patients with acromegaly. Bromocriptine has been associated with pulmonary fibrosis. G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist C26170 - Protective Agent > C1509 - Neuroprotective Agent
Elsamitrucin
Cyanidin 3-(6-acetylglucoside)-5-glucoside
Delphinidin 3-[6-(2-acetylrhamnosyl)glucoside]
Hirsutidin 3-O-(6-O-p-coumaroyl)glucoside
2,6,14-Triacetoxy-1-benzoyloxydihydro-9-nicotinoyloxy-beta-agarofuran
1beta,5alpha,11-triacetoxy-7beta-benzoyl-4alpha-hydroxy-8beta-nicotinoyl-dihydroagarofuran|1??,5??,11-Triacetoxy-7??-benzoyl-4??-hydroxy-8??-nicotinoyl-dihydroagarofuran
1alpha-nicotinoyloxy-2alpha-acetoxy-6beta-acetoxy-9beta-benzoyloxy-11-acetoxy-4beta-hydroxydihydro-beta-agarofuran|1??-Nicotinoyloxy-2??-acetoxy-6??-acetoxy-9??-benzoyloxy-11-acetoxy-4??-hydroxydihydro-??-agarofuran|2,6,14-Triacetoxy-9-(benzoyloxy)dihydro-1-nicotinoyloxy-beta-agarofuran
Bromocriptine
G - Genito urinary system and sex hormones > G02 - Other gynecologicals > G02C - Other gynecologicals > G02CB - Prolactine inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist C26170 - Protective Agent > C1509 - Neuroprotective Agent
Elsamitrucin
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents
tetrasodium N-(3-carboxylato-1-oxo-2-sulphonatopropyl)-N-octadecyl-L-aspartate
C26H43NNa4O10S (653.2198338000001)
4-[[5-[[[4-(aminocarbonyl)phenyl]amino]carbonyl]-2-methoxyphenyl]azo]-N-(5-chloro-2,4-dimethoxyphenyl)-3-hydroxynaphthalene-2-carboxamide
C34H28ClN5O7 (653.1677168000001)
Elagolix sodium
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2092 - Gonadotropin Releasing Hormone Antagonist
Precursor of cefcapene diisopropylanmine salt
C29H43N5O8S2 (653.2552918000001)
(9R)-5-Bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
(6Ar)-5-bromo-N-[(1S,4R)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
4-chloro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]benzenesulfonamide
Delphinidin 3-[6-(2-acetylrhamnosyl)glucoside]
C29H33O17+ (653.1717668000001)
(6aS,9R)-5-bromo-N-[(1R,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
(8S)-2-Bromo alpha-ergocryptine
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists
ferrioxamine E
An Fe(III)-complexed hydroxamate siderophore consisting of norcardamine (desferrioxamine E) complexed to iron(III).
3-{[(2s,3r,4s,5s,6r)-6-({[(2r,3s,4r,5r,6s)-3-(acetyloxy)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
[C29H33O17]+ (653.1717668000001)
(1s,2r,4s,5r,6s,7s,8r,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate
4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-5-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-8-yl pyridine-3-carboxylate
(3s,4r,4as,5ar)-4-ethenyl-8-hydroxy-3,7-bis({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
(1r,2s,4s,5s,6s,7s,9s,12s)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
3-{[(2s,3r,4s,5s,6r)-6-({[(2r,3s,4r,5s,6s)-4-(acetyloxy)-3,5-dihydroxy-6-methyloxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium
[C29H33O17]+ (653.1717668000001)
1α-nicotinoyloxy-2α-acetoxy-6β-acetoxy-9β-benzoyloxy-11-acetoxy-4β-hydroxydihydro-β-agarofuran
{"Ingredient_id": "HBIN002312","Ingredient_name": "1\u03b1-nicotinoyloxy-2\u03b1-acetoxy-6\u03b2-acetoxy-9\u03b2-benzoyloxy-11-acetoxy-4\u03b2-hydroxydihydro-\u03b2-agarofuran","Alias": "NA","Ingredient_formula": "C34H39NO12","Ingredient_Smile": "CC(=O)OCC12C(CC3C(C1(C(CC(C2OC(=O)C4=CN=CC=C4)OC(=O)C)(C)O)OC3(C)C)OC(=O)C)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "15525","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
(1s,2s,5s,6s,7s,8r,9r,12r)-5,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-8-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl pyridine-3-carboxylate
(4r,7r)-10-bromo-n-[(1s,2s,4r,7s)-2-hydroxy-4-isopropyl-7-(2-methylpropyl)-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0²,⁶]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid
(1s,2s,4s,5r,6r,7s,9r,12r)-4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
4-ethenyl-8-hydroxy-3,7-bis({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})-4,4a,5,5a,10,11-hexahydro-3h-2-oxa-12-azatetraphen-13-one
4,12-bis(acetyloxy)-6-[(acetyloxy)methyl]-7-(benzoyloxy)-2-hydroxy-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl pyridine-3-carboxylate
5-{[(2s,3r,4s,5s,6r)-6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-3-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
[C29H33O17]+ (653.1717668000001)